Adagene Announces Clinical Trial Collaboration to Evaluate - GlobeNewswire

Retrieved on: 2022-12-16 11:34:01

Tags for this article:

Medicine

Clinical medicine

Hepatocellular carcinoma

Bevacizumab

Liver cancer

Programmed cell death protein 1

China

Adagene Inc.

Click the tags to see associated articles and topics

Adagene Announces Clinical Trial Collaboration to Evaluate - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2022/12/16/2575333/0/en/Adagene-Announces-Clinical-Trial-Collaboration-to-Evaluate-Anti-CTLA-4-SAFEbody-ADG126-in-Combination-with-Roche-s-Standard-of-Care-for-First-Line-Advanced-Liver-Cancer.html

Excerpt

The collaboration will utilize Roche's MORPHEUS-LIVER platform for rapid and efficient combination development. Under the collaboration, Roche will ...

Article found on: www.globenewswire.com

View Original Article